News

Scientists are now better able to predict how quickly the HIV virus will return after individuals stop treatment following a discovery by researchers at UNSW Australia and the University of Oxford. The significant development, ...

The Kirby Institute is pleased to announce the election of three of our celebrated leaders to the Australian Academy of Health and Medical Sciences (AAHMS). Scientia Professor John Kaldor, Professor Anthony Kelleher and Professor ...

Experts call for immediate access to new generation therapies for hepatitis C (Sydney, Wednesday 7 October 2015) Treating hepatitis C in people who inject drugs is the most cost effective way to address the sharp increase in liver ...

The World Health Organization has launched new guidelines for the treatment and prevention of HIV which reflect conclusive evidence from studies conducted by leading HIV research organisations, including the Kirby Institute at UNSW ...

Professor Lisa Maher, Head of the Viral Hepatitis Epidemiology and Prevention Program at the Kirby Institute has been elected as one of thirty new fellows to the Academy of Social Sciences in Australia (ASSA). Professor Maher is ...

Researchers have successfully tested a new drug that activates hidden reservoirs of HIV cells in individuals on antiretroviral therapy, one of the first steps to eradicating the virus and eventually finding a cure. The study, led ...

Gay and bisexual men test for HIV more often when rapid tests are available at clinics according to a new study from the Kirby Institute at UNSW, presented today at the World HIV and STI 2015 Congress and Australasian HIV and AIDS ...

Australia is close to achieving global targets for the testing and treatment of HIV, but more needs to be done to identify and treat infections early, according to a new report by the Kirby Institute at UNSW Australia, released today ...

The Kirby Institute at UNSW Australia will collaborate with the Papua New Guinea Institute of Medical Research (PNGIMR) and other national and international institutes to conduct a world-first study in maternal and newborn health in PNG.

The Kirby Institute, in partnership with the Positive Leadership Development Institute (PLDI™ Australia) has today launched the inaugural Kirby Institute Community Scholarship, which will support people living with HIV to attend ...

28 July (SYDNEY, AUSTRALIA) - Opiate substitution therapy can protect against hepatitis C virus acquisition in people who inject drugs, according to a world-first study conducted by the Kirby Institute and collaborators ...

Tuesday 28 July 2015 is World Hepatitis Day with Hepatitis Australia calling for action on viral hepatitis for the almost half a million Australians who are living with hepatitis B or C. The World Health Organization is encouraging the ...

In celebration of NAIDOC week, the Kirby Institute has a created a booklet which showcases our Aboriginal and Torres Strait Islander research. Aboriginal people are one of the priority populations for research conducted at the Kirby ...

3 July 2015 (SYDNEY, AUSTRALIA) - In a new study from the Kirby Institute at UNSW Australia, researchers have found that HIV cells in the body of a person receiving antiretroviral treatment become activated 24 times less frequently ...

Medicaid restrictions on access to a breakthrough treatment for viral hepatitis C infection hit the poorest and most underserved patients the hardest, suggests data from a new study published today in the Annals of Internal Medicine. Res

(SYDNEY, AUSTRALIA (16 June 2015) Released today, the first ever review of the prevalence of scabies and impetigo worldwide shows clearly where the hotspots and gaps are for these debilitating infectious diseases. According to a ...

The number of young Australians injecting drugs has declined over 20 years, heroin and methamphetamine remain the two most commonly reported drugs last injected, and transmission of HIV related to injecting drug use has been ...

Men who have recently tested positive for HIV are more comfortable with the idea of committing to a treatment regimen soon after diagnosis than they were a few years ago, suggest results presented in the latest HIV Seroconverstion ...